NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹368 Cr | ₹339 Cr | ₹278 Cr | ₹318 Cr | ₹258 Cr |
What is the latest Revenue of NGL FINECHEM ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹368 Cr |
| Mar2025 | ₹339 Cr |
| Mar2024 | ₹278 Cr |
| Mar2023 | ₹318 Cr |
| Mar2022 | ₹258 Cr |
How is Revenue of NGL FINECHEM Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹368 Cr | 8.73 | |
| Mar2025 | ₹339 Cr | 21.79 | |
| Mar2024 | ₹278 Cr | -12.42 | |
| Mar2023 | ₹318 Cr | 23.08 | |
| Mar2022 | ₹258 Cr | - | |
Compare Revenue of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,737.3 Cr | -4.2% | 9.4% | 94.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -4.2% |
9.4% |
94.1% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses